| __timestamp | ADMA Biologics, Inc. | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 12199547 |
| Thursday, January 1, 2015 | 7015946 | 16054000 |
| Friday, January 1, 2016 | 7688238 | 23316000 |
| Sunday, January 1, 2017 | 6229587 | 10626000 |
| Monday, January 1, 2018 | 3926120 | 28970000 |
| Tuesday, January 1, 2019 | 2343848 | 35847000 |
| Wednesday, January 1, 2020 | 5907013 | 27185000 |
| Friday, January 1, 2021 | 3646060 | 58742000 |
| Saturday, January 1, 2022 | 3613764 | 70243000 |
| Sunday, January 1, 2023 | 3300000 | 80904000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and ADMA Biologics, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Alpine Immune Sciences, Inc. has consistently increased its R&D expenses, peaking at approximately $81 million in 2023, a remarkable 560% increase from 2014. This upward trend underscores their aggressive pursuit of cutting-edge therapies. In contrast, ADMA Biologics, Inc. has shown a more conservative approach, with R&D spending decreasing by about 65% over the same period, from $9.5 million in 2014 to $3.3 million in 2023.
These spending patterns reflect each company's strategic priorities and market positioning, offering valuable insights into their future growth trajectories.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.